Arakawa's syndrome II

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics

Arakawa's syndrome II
Structure of Mecobalamin
Synonyms
Pronounce
Specialty	Medical genetics
Symptoms	Developmental delay, intellectual disability, seizures, hypotonia
Complications	N/A
Onset	Infancy
Duration	Lifelong
Types	N/A
Causes	Genetic mutation
Risks
Diagnosis	Genetic testing, clinical evaluation
Differential diagnosis
Prevention
Treatment	Supportive care, symptomatic treatment
Medication
Prognosis
Frequency	Rare disease
Deaths

A rare genetic disorder

Arakawa's syndrome II

Arakawa's syndrome II is a rare genetic disorder characterized by a combination of neurological, musculoskeletal, and developmental abnormalities. It is part of a group of conditions known as congenital disorders of glycosylation (CDG), which affect the process of glycosylation, a critical biochemical pathway in the body.

Presentation

Individuals with Arakawa's syndrome II typically present with a variety of symptoms that can vary in severity. Common features include:

• Hypotonia (reduced muscle tone)
• Developmental delay
• Intellectual disability
• Seizures
• Distinctive facial features

Neurological Features

The neurological manifestations of Arakawa's syndrome II are significant and often include seizures, which can be difficult to control. Developmental delay is common, affecting both motor and cognitive skills. Intellectual disability is also frequently observed.

Musculoskeletal Abnormalities

Patients may exhibit hypotonia, which can lead to difficulties with movement and posture. Some individuals may have joint contractures or other skeletal anomalies.

Facial Dysmorphism

Distinctive facial features may be present, including a prominent forehead, wide-set eyes, and a flat nasal bridge. These features can aid in the clinical diagnosis of the syndrome.

Genetics

Arakawa's syndrome II is caused by mutations in genes involved in the glycosylation pathway. This pathway is essential for the proper functioning of many proteins and lipids in the body. The specific genetic mutations responsible for this syndrome disrupt normal glycosylation, leading to the wide array of symptoms observed.

Diagnosis

Diagnosis of Arakawa's syndrome II is based on clinical evaluation, genetic testing, and biochemical assays to assess glycosylation status. Genetic testing can confirm the presence of mutations associated with the syndrome.

Management

There is currently no cure for Arakawa's syndrome II, and treatment is primarily supportive. Management strategies may include:

• Physical therapy to improve muscle tone and mobility
• Occupational therapy to assist with daily living skills
• Speech therapy for communication difficulties
• Anticonvulsant medications to control seizures

Prognosis

The prognosis for individuals with Arakawa's syndrome II varies depending on the severity of symptoms and the effectiveness of management strategies. Early intervention and supportive therapies can improve quality of life and functional outcomes.

See also

• Congenital disorders of glycosylation
• Genetic disorder
• Neurological disorder